Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?

@article{Vuppalanchi2007EtiologyON,
  title={Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States?},
  author={Raj Vuppalanchi and Suthat Liangpunsakul and Naga P. Chalasani},
  journal={The American Journal of Gastroenterology},
  year={2007},
  volume={102},
  pages={558-562}
}
BACKGROUND AND AIM:The epidemiology of acute drug-induced liver injury (DILI) in the United States has not been well studied. We conducted a study of adults with new-onset jaundice at a nonreferral community hospital to better understand the epidemiology of acute DILI.METHODS:This is a retrospective study of adult outpatients and inpatients (≥18 yr) with new-onset jaundice over a 5-yr period (1999–2003) at Wishard Memorial Hospital, Indiana. Patients with new-onset jaundice were identified… 

Tables from this paper

Cholestasis in a Patient of Multiple Myeloma: A Rare Occurrence of Bortezomib Induced Liver Injury

TLDR
A 54 yearsold non-alcoholic man who initially presented to his hematology clinic with complaints of backache of 3 months duration is reported, currently with jaundice and pruritus 2 days after receiving second dose of bortezomib during second cycle of CyBorD.

Global Epidemiology of Drug-Induced Liver Injury (DILI)

TLDR
Although large DILI registries from Europe and the USA have collected much data, more prospective studies with continual enrollment are needed particularly as new therapies such as immune modulatory and oncological medications with longer half-lives and latencies come to market.

Drug-induced liver injury in 2007

TLDR
The year 2007 brought with it several reminders of the importance of drug-induced liver injury in the clinical trial as well as the clinical practice setting, and there is additional evidence that statin drugs may be used safely in patients with chronic liver disease.

ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.

TLDR
Patients with DILI who develop progressive jaundice with or without coagulopathy should be referred to a tertiary care center for specialized care, including consideration for potential liver transplantation.

Jaundice in Adult in-Patients at a Tertiary General Hospital

TLDR
At tertiary hospital, jaundice is common sign in adult patient, diverse enormously in many clinical wards, and independent risk factors for treatment failure were found.

Epidemiology of idiosyncratic drug-induced liver injury.

TLDR
The epidemiology of DILI, both in the general population and in potentially high-risk subgroups, is reviewed and it is extrapolated that nearly 44,000 individuals in the United States will suffer from DILi each year.

Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

TLDR
The profile of liver injury at presentation, initial severity, patient's race, and medical comorbidities are important determinants of the likelihood of death/transplantation or persistent liver injury within 6 months of DILI onset.

Drug-Induced Liver Injury: Clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China

  • Yao LiuS. Zhan Peiyuan Xia
  • Medicine
    Medical science monitor : international medical journal of experimental and clinical research
  • 2020
TLDR
The study provides a systematic etiological profile of DILI in Chinese patients, which can represent references for prevention, diagnosis and treatment, supporting and promoting efforts to ease the burden of this liver disease in China.

Drug-induced liver injury: present and future

TLDR
A more objective and reproducible tool that could be used for the diagnosis of DILI caused by 'herbs' is needed in Asia, and a reporting system similar to the Drug-Induced Liver Injury Network (DILIN) in the US should be established as soon as possible in Asia.

Review article: drug-induced liver injury in clinical practice

TLDR
A review of the recent data on DILI with particular focus on the most common and relevant issues seen in clinical practice is provided, to increase the understanding of liver injury associated with drugs.
...

References

SHOWING 1-10 OF 14 REFERENCES

The Burden of Acute Nonfulminant Drug-induced Hepatitis in a United States Tertiary Referral Center

TLDR
Drug-induced hepatitis is an uncommon entity in clinical hepatology but does represent a significant proportion of acute self-limited liver disease in the United States and time to resolution after discontinuation of the offending agent may be protracted.

Outcome and prognostic markers in severe drug‐induced liver disease

TLDR
Age, aspartate aminotransferase (AST) and bilirubin were found to independently predict death or liver transplantation in the hepatocellular group, whereas among patients with cholestatic/mixed liver injury, bilirUBin was the only independent predictor.

Severe Jaundice in Sweden in the New Millennium: Causes, Investigations, Treatment and Prognosis

TLDR
Malignancy and alcoholic liver disease are the most common causes of severe jaundice, whereas viral hepatitis is a rare cause.

Incidence of drug‐induced hepatic injuries: A French population‐based study

TLDR
The results suggest that the number of hepatic ADRs in the French population would be 16 times greater than the number noted by spontaneous reporting to French regulatory authorities.

Drug‐induced hepatic injury: an analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987

TLDR
The Danish Committee on Adverse Drug Reactions received 1100 reports of suspected drug‐induced hepatic injury during the decade 1978–1987, and halothane was the drug most often suspected during the last 2 years of the decade.

The significance of alcoholic liver disease to contemporary clinical hepatology

TLDR
The more detailed conclusions of the Byron and Minuk report are clearly influenced by the design of their study, and several points require amplification and comment.

Patients with Elevated Baseline Liver Enzymes Do Not Have Higher Frequency of Hepatotoxicity from Lovastatin than Those with Normal Baseline Liver Enzymes

TLDR
Significant hepatotoxicity from lovastatin was very infrequent in this study, and individuals with elevated baseline liver enzyme levels did not have higher frequency of Lovastatin hepatot toxicity than those with normal liver enzymes levels.

Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results from a prospective study.

TLDR
Serum bilirubin and alkaline phosphatase seem to be the most potential tests of these laboratory tests in distinguishing benign and malignant causes of jaundice and/or cholestasis, high levels being suggestive of malignant disease.